Company profile ELEV
After 39 days of this quarter the interest is at 157.0. Based on that we can calculate that during remaining 52 days it will total up to 366.0. Elevation Oncology expected interest is significantly higher compared to previous quarter (+195.2%) and same quarter last year (+76.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 36 | 77 113.9% QoQ | 77 0.0% QoQ | 146 89.6% QoQ |
| 2020 | 96 166.7% YoY -34.2% QoQ | 17 -77.9% YoY -82.3% QoQ | 217 181.8% YoY 1176.5% QoQ | 164 12.3% YoY -24.4% QoQ |
| 2021 | 80 -16.7% YoY -51.2% QoQ | 159 835.3% YoY 98.8% QoQ | 371 71.0% YoY 133.3% QoQ | 41 -75.0% YoY -88.9% QoQ |
| 2022 | 152 90.0% YoY 270.7% QoQ | 225 41.5% YoY 48.0% QoQ | 108 -70.9% YoY -52.0% QoQ | 171 317.1% YoY 58.3% QoQ |
| 2023 | 208 36.8% YoY 21.6% QoQ | 508 125.8% YoY 144.2% QoQ | 76 -29.6% YoY -85.0% QoQ | 124 -27.5% YoY 63.2% QoQ |
| 2024 | 157 -24.5% YoY 26.6% QoQ | - | - | - |
The average 5 years interest of Elevation Oncology was 12.3 per week. The last year interest of Elevation Oncology compared to the last 5 years has changed by 56.18%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 175.21%.
There is not enough data for EO-3021 clinical trials to provide analysis
There is not enough data for EO-3021 clinical trials to provide correlation calculation
There is not enough data for EO-3021 clinical trials to provide analysis
After 34 days of this quarter the interest is at 17.0. Based on that we can calculate that during remaining 58 days it will total up to 46.0. Claudin 18.2 expected interest is significantly lower compared to previous quarter (-74.9%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 47 |
| 2019 | 48 2.1% QoQ | 0 -100.0% QoQ | 125 inf% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2020 | 30 -37.5% YoY inf% QoQ | 24 inf% YoY -20.0% QoQ | 49 -60.8% YoY 104.2% QoQ | 205 inf% YoY 318.4% QoQ |
| 2021 | 94 213.3% YoY -54.1% QoQ | 78 225.0% YoY -17.0% QoQ | 88 79.6% YoY 12.8% QoQ | 29 -85.9% YoY -67.0% QoQ |
| 2022 | 221 135.1% YoY 662.1% QoQ | 138 76.9% YoY -37.6% QoQ | 78 -11.4% YoY -43.5% QoQ | 74 155.2% YoY -5.1% QoQ |
| 2023 | 206 -6.8% YoY 178.4% QoQ | 191 38.4% YoY -7.3% QoQ | 183 134.6% YoY -4.2% QoQ | 17 -77.0% YoY -90.7% QoQ |
The average 5 years interest of Claudin 18.2 was 7.4 per week. The last year interest of Claudin 18.2 compared to the last 5 years has changed by 74.32%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 204.96%.
After 39 days of this quarter the interest is at 123.0. Based on that we can calculate that during remaining 52 days it will total up to 287.0. Elevation Oncology IPO expected interest is significantly higher compared to previous quarter (+1693.8%) and same quarter last year (+1147.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 15 inf% QoQ | 44 193.3% QoQ | 30 -31.8% QoQ |
| 2020 | 20 inf% YoY -33.3% QoQ | 33 120.0% YoY 65.0% QoQ | 37 -15.9% YoY 12.1% QoQ | 53 76.7% YoY 43.2% QoQ |
| 2021 | 8 -60.0% YoY -84.9% QoQ | 33 0.0% YoY 312.5% QoQ | 7 -81.1% YoY -78.8% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 25 212.5% YoY inf% QoQ | 12 -63.6% YoY -52.0% QoQ | 19 171.4% YoY 58.3% QoQ | 34 inf% YoY 78.9% QoQ |
| 2023 | 23 -8.0% YoY -32.4% QoQ | 15 25.0% YoY -34.8% QoQ | 16 -15.8% YoY 6.7% QoQ | 16 -52.9% YoY 0.0% QoQ |
| 2024 | 123 434.8% YoY 668.8% QoQ | - | - | - |
The average 5 years interest of Elevation Oncology IPO was 2.16 per week. The last year interest of Elevation Oncology IPO compared to the last 5 years has changed by 65.74%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 84.54%.
There is not enough data for Elevation Oncology news to provide analysis
There is not enough data for Elevation Oncology news to provide correlation calculation
There is not enough data for Elevation Oncology news to provide analysis
After 39 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 52 days it will total up to 61.0. Elevation Oncology stock expected interest is significantly lower compared to same quarter last year (-70.4%) but higher than previous quarter (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 40 | 50 25.0% QoQ | 132 164.0% QoQ | 129 -2.3% QoQ |
| 2020 | 52 30.0% YoY -59.7% QoQ | 45 -10.0% YoY -13.5% QoQ | 33 -75.0% YoY -26.7% QoQ | 109 -15.5% YoY 230.3% QoQ |
| 2021 | 127 144.2% YoY 16.5% QoQ | 168 273.3% YoY 32.3% QoQ | 31 -6.1% YoY -81.5% QoQ | 166 52.3% YoY 435.5% QoQ |
| 2022 | 81 -36.2% YoY -51.2% QoQ | 73 -56.5% YoY -9.9% QoQ | 127 309.7% YoY 74.0% QoQ | 80 -51.8% YoY -37.0% QoQ |
| 2023 | 206 154.3% YoY 157.5% QoQ | 231 216.4% YoY 12.1% QoQ | 92 -27.6% YoY -60.2% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2024 | 26 -87.4% YoY inf% QoQ | - | - | - |
The average 5 years interest of Elevation Oncology stock was 7.66 per week. The last year interest of Elevation Oncology stock compared to the last 5 years has changed by 9.01%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 17.11%.
There is not enough data for Elevation Oncology conferences to provide analysis
There is not enough data for Elevation Oncology conferences to provide correlation calculation
There is not enough data for Elevation Oncology conferences to provide analysis
There is not enough data for Elevation Oncology partnerships to provide analysis
There is not enough data for Elevation Oncology partnerships to provide correlation calculation
There is not enough data for Elevation Oncology partnerships to provide analysis
There is not enough data for Elevation Oncology careers to provide analysis
There is not enough data for Elevation Oncology careers to provide correlation calculation
There is not enough data for Elevation Oncology careers to provide analysis
There is not enough data for Elevation Oncology patient testimonials to provide analysis
There is not enough data for Elevation Oncology patient testimonials to provide correlation calculation
There is not enough data for Elevation Oncology patient testimonials to provide analysis